With many years of experience in public and private financings, investor relations, and company and product acquisition negotiations, Mr. Mast currently serves as chief financial officer of Pharmion Corporation. Mr. Mast was previously the chief financial officer of the Biopharmaceutical Business Unit of Elan Corporation after Elan’s acquisition of Dura Pharmaceuticals, Inc. in 2000. He also served as vice president of Finance for Dura prior to the acquisition.

Mr. Mast is a former partner at Deloitte & Touche, LLP, where he focused on health care services, pharmaceutical, biotech and manufacturing clients with an emphasis on serving SEC clients. Mr. Mast graduated from California State University Bakersfield with a degree in Business Administration.